CBT
CBT
NYSE · Chemicals

Cabot Corp

$76.59
-0.85 (-1.10%)
Financial Highlights (FY 2026)
Revenue
3.58B
Net Income
318.73M
Gross Margin
25.3%
Profit Margin
8.9%
Rev Growth
-4.9%
D/E Ratio
0.73
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 25.3% 25.3% 49.7% 49.7%
Operating Margin 16.7% 15.1% 9.8% 10.6%
Profit Margin 8.9% 8.5% 7.8% 8.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.58B 3.76B 185.80M 154.67M
Gross Profit 905.28M 952.23M 92.35M 76.88M
Operating Income 598.16M 566.26M 18.27M 16.44M
Net Income 318.73M 301.73M 14.53M 13.23M
Gross Margin 25.3% 25.3% 49.7% 49.7%
Operating Margin 16.7% 15.1% 9.8% 10.6%
Profit Margin 8.9% 8.5% 7.8% 8.6%
Rev Growth -4.9% -4.9% +7.5% +12.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 852.05M 852.05M 777.42M 779.25M
Total Equity 1.17B 1.17B 2.58B 2.20B
D/E Ratio 0.73 0.73 0.30 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 746.27M 745.73M 24.94M 19.49M
Free Cash Flow 7.01M 6.93M